Highlight publications
De Brito, SA, McDonald, D, Camilleri, JA & Rogers, JC 2021, 'Cortical and subcortical gray matter volume in psychopathy: a voxel-wise meta-analysis.', Journal of Abnormal Psychology, vol. 130, no. 6, pp. 627-640. https://doi.org/10.1037/abn0000698
Rogers, JC & De Brito, SA 2016, 'Cortical and subcortical gray matter volume in youths with conduct problems: A meta-analysis', JAMA psychiatry, vol. 73, no. 1, pp. 64-72. https://doi.org/10.1001/jamapsychiatry.2015.2423
Rogers, JC, Gonzalez-Madruga, K, Kohls, G, Baker, RH, Clanton, RL, Pauli, R, Birch, P, Chowdhury, AI, Kirchner, M, Andersson, JLR, Smaragdi, A, Puzzo, I, Baumann, S, Raschle, NM, Fehlbaum, LV, Menks, WM, Steppan, M, Stadler, C, Konrad, K, Freitag, CM, Fairchild, G & De Brito, SA 2019, 'White matter microstructure in youths with conduct disorder: effects of sex and variation in callous traits', Journal of the American Academy of Child and Adolescent Psychiatry, vol. 58, no. 12, pp. 1184-1196. https://doi.org/10.1016/j.jaac.2019.02.019
Rogers, J & Broome, M 2020, 'Effectiveness of multisystemic therapy for adolescent antisocial behaviour: follow-up findings from the START trial', The Lancet Psychiatry, vol. 7, no. 5, pp. 375-376. https://doi.org/10.1016/S2215-0366(20)30167-X
Hett, D, Rogers, J, Humpston, C & Marwaha, S 2021, 'Repetitive transcranial magnetic stimulation (rTMS) for the treatment of depression in adolescence: a systematic review', Journal of Affective Disorders, vol. 278, pp. 460-469. https://doi.org/10.1016/j.jad.2020.09.058
Recent publications
Article
De Brito, SA, Rogers, JC, Pauli, R, Kohls, G, Raschle, NM, Martinelli, A, Smaragdi, A, Gonzalez-Madruga, K, Cornwell, H, Stadler, C, Konrad, K, Freitag, CM & Fairchild, G 2025, 'Brain Responses During Face Processing in Conduct Disorder: Considering Sex and Callous-Unemotional Traits', Biological Psychiatry. https://doi.org/10.1016/j.biopsych.2025.04.023
Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ), Allott, K, Yassin, W, Alameda, L, Billah, T, Borders, O, Buccilli, K, Carrión, RE, Castillo-Passi, RI, Cho, KIK, Chin, K, Coleman, MJ, Colton, B-L, Corral, S, Dwyer, D, Gundersen, KB, Gur, RC, Hoftman, GD, Jacobs, GR, Kelly, S, Lewandowski, KE, Marcy, PJ, Matneja, P, McLaughlin, D, Nunez, AR, Parsa, S, Penzel, N, Ray, S, Reinen, JM, Ruparel, K, Sand, MS, Santorelli, G, Seitz-Holland, J, Spark, J, Tamayo, Z, Thompson, A, Tod, S, Wannan, CMJ, Wickham, A, Wood, SJ, Zoupou, E, Addington, J, Anticevic, A, Arango, C, Breitborde, NJK, Broome, MR, Cadenhead, KS, Calkins, ME, Chen, EYH, Choi, J, Conus, P, Corcoran, CM, Cornblatt, BA, Ellman, LM, Fusar-Poli, P, Gaspar, PA, Gerber, C, Glenthøj, LB, Horton, LE, Hui, CLM, Kambeitz, J, Kambeitz-Ilankovic, L, Keshavan, M, Kim, SW, Koutsouleris, N, Kwon, JS, Langbein, K, Mamah, D, Diaz‐Caneja, CM, Mathalon, DH, Mittal, VA, Nordentoft, M, Pearlson, GD, Perkins, DO, Perez, J, Powers III, AR, Rogers, J, Sabb, FW, Schiffman, J, Shah, JL, Silverstein, SM, Smesny, S, Strauss, GP, Thompson, JL, Upthegrove, R, Verma, SK, Wang, J, Wolf, DH, Pasternak, O, Bouix, S, McGorry, PD, Kane, JM, Kahn, RS, Bearden, CE, Shenton, ME, Woods, SW, Nelson, B & Stone, WS 2025, 'Cognitive assessment in the Accelerating Medicines Partnership® Schizophrenia Program: harmonization priorities and strategies in a diverse international sample', Schizophrenia, vol. 11, no. 1, 49. https://doi.org/10.1038/s41537-025-00578-1
Bilgrami, ZR, Broome, MR, Rogers, J, Upthegrove, R, Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ) & Wolff, PM 2025, 'Collecting language, speech acoustics, and facial expression to predict psychosis and other clinical outcomes: strategies from the AMP® SCZ initiative', Schizophrenia, vol. 11, no. 1, 125. https://doi.org/10.1038/s41537-025-00669-z
Wigman, JTW, Ching, AE, Chung, Y, Eichi, HR, Lane, E, Langholm, C, Vaidyam, A, Byun, AJS, Haidar, A, Hartmann, J, Nunez, A, Dwyer, D, Nasarudin, AA, Borders, O, Scott, I, Tamayo, Z, Matneja, P, Cho, K-I, Addington, J, Alameda, LK, Arango, C, Breitborde, NJK, Broome, MR, Cadenhead, KS, Calkins, ME, Chen, EYH, Choi, J, Conus, P, Corcoran, CM, Cornblatt, BA, Diaz-Caneja, CM, Ellman, LM, Fusar-Poli, P, Gaspar, PA, Gerber, C, Glenthøj, LB, Horton, LE, Hui, CLM, Kambeitz, J, Kambeitz-Ilankovic, L, Keshavan, MS, Kim, S-W, Koutsouleris, N, Langbein, K, Mamah, D, Mathalon, DH, Mittal, VA, Nordentoft, M, Pearlson, GD, Perez, J, Perkins, DO, Powers, III, AR, Rogers, J, Sabb, FW, Schiffman, J, Shah, JL, Silverstein, SM, Smesny, S, Yassin, W, Stone, WS, Strauss, GP, Thompson, JL, Upthegrove, R, Verma, S, Wang, J, Wolf, DH, Wolff, P, Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ), Rowland, LM, D'Alfonso, S, Pasternak, O, Bouix, S, McGorry, PD, Kahn, RS, Kane, JM, Bearden, CE, Woods, SW, Shenton, ME, Nelson, B, Baker, JT & Torous, J 2025, 'Digital health technologies in the accelerating medicines Partnership® Schizophrenia Program', Schizophrenia, vol. 11, no. 1, 83. https://doi.org/10.1038/s41537-025-00599-w
Eaton, S, Cornwell, H, Rogers, J, De Brito, S, Toschi, N, Stadler, C, Raschle, N, Konrad, K, Kohls, G, Smaragdi, A, Gonzalez-Madruga, K, Oosterling, M, Martinelli, A, Bernhard, A, Freitag, CM, Hamilton-Giachritsis, C & Fairchild, G 2025, 'Neural activation during processing of emotional faces as a function of resilience in adolescents', European Child and Adolescent Psychiatry. https://doi.org/10.1007/s00787-025-02703-y
Addington, J, Liu, L, Braun, A, Auther, A, Calkins, ME, Cornblatt, BA, Corcoran, CM, Fusar-Poli, P, Kerr, MJ, Mourgues-Codern, CV, Nunez, AR, Oliver, D, Strauss, GP, Walsh, BC, Alameda, LK, Arango, C, Breitborde, NJK, Broome, MR, Cadenhead, KS, Carrion, RE, Chen, EYH, Choi, J, Coleman, MJ, Conus, P, Diaz-Caneja, CM, Dwyer, D, Ellman, LM, Faghankhani, M, Gaspar, PA, Gerber, C, Glenthøj, LB, Horton, LE, Hui, C, Jacobs, GR, Kambeitz, J, Kambeitz-Ilankovic, L, Keshavan, MS, Kim, S-W, Koutsouleris, N, Kwon, JS, Langbein, K, Lewandowski, KE, Mamah, D, Marcy, PJ, Mathalon, DH, Mittal, VA, Nordentoft, M, Pearlson, GD, Penzel, N, Perez, J, Perkins, DO, Powers, III, AR, Rogers, J, Sabb, FW, Schiffman, J, Shah, JL, Silverstein, SM, Smesny, S, Stone, WS, Thompson, A, Thompson, JL, Upthegrove, R, Verma, S, Wang, J, Wastler, HM, Wickham, A, Winter-van Rossum, I, Wolf, DH, Bouix, S, Pasternak, O, Kahn, RS, Bearden, CE, Kane, JM, McGorry, PD, Buccilli, K, Nelson, B, Shenton, ME, Woods, SW, the Accelerating Medicines Partnership® -Schizophrenia & Yung, AR 2025, 'Sample ascertainment and clinical outcome measures in the Accelerating Medicines Partnership® Schizophrenia Program', Schizophrenia, vol. 11, no. 1, 54. https://doi.org/10.1038/s41537-025-00556-7
Addington, J, Broome, MR, Rogers, J, Upthegrove, R & Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ) 2025, 'Sample Ascertainment and Recruitment Sources in the Accelerating Medicines Partnership Schizophrenia Program', Schizophrenia Bulletin Open, vol. 6, no. 1, sgaf013. https://doi.org/10.1093/schizbullopen/sgaf013
Townend, S, Staginnus, M, Rogers, J, Smaragdi, A, Martinelli, A, Bernhard, A, Raschle, NM, Kohls, G, Konrad, K, Stadler, C, Freitag, CM, Walton, E, De Brito, SA & Fairchild, G 2025, 'Testing the ecophenotype hypothesis: Differences in white matter microstructure in youth with conduct disorder with versus without a history of childhood abuse', Development and Psychopathology. https://doi.org/10.1017/S0954579425000367
Mathalon, DH, Nicholas, S, Roach, BJ, Billah, T, Lavoie, S, Whitford, T, Hamilton, HK, Addamo, L, Anohkin, A, Bekinschtein, T, Belger, A, Buccilli, K, Cahill, J, Carrión, RE, Damiani, S, Dzafic, I, Ebdrup, BH, Izyurov, I, Jarcho, J, Jenni, R, Jo, A, Kerins, S, Lee, C, Martin, EA, Mayol-Troncoso, R, Niznikiewicz, MA, Parvaz, M, Pogarell, O, Prieto-Montalvo, J, Rabin, R, Roalf, DR, Rogers, J, Salisbury, DF, Shaik, R, Shankman, S, Stevens, MC, Suen, YN, Swann, NC, Tang, X, Thompson, JL, Tso, I, Wenzel, J, Zhou, JH, Addington, J, Alameda, L, Arango, C, Breitborde, NJK, Broome, MR, Cadenhead, KS, Calkins, ME, Castillo-Passi, RI, Chen, EYH, Choi, J, Conus, P, Corcoran, CM, Cornblatt, BA, Diaz‐Caneja, CM, Ellman, LM, Fusar-Poli, P, Gaspar, PA, Gerber, C, Glenthøj, LB, Horton, LE, Hui, CLM, Kambeitz, J, Kambeitz-Ilankovic, L, Keshavan, MS, Kim, M, Kim, S-W, Koutsouleris, N, Kwon, JS, Langbein, K, Mamah, D, Mittal, VA, Nordentoft, M, Pearlson, GD, Perez, J, Perkins, DO, Powers, AR, Sabb, FW, Schiffman, J, Shah, JL, Silverstein, SM, Smesny, S, Stone, WS, Strauss, GP, Upthegrove, R, Verma, SK, Wang, J, Wolf, DH, Zhang, T, Bouix, S, Pasternak, O, Cho, K-IK, Coleman, MJ, Dwyer, D, Nunez, A, Tamayo, Z, Wood, SJ, Kahn, RS, Kane, JM, McGorry, PD, Bearden, CE, Nelson, B, Woods, SW, Shenton, ME, Accelerating Medicines Partnership® Schizophrenia Program & Light, GA 2025, 'The electroencephalography protocol for the Accelerating Medicines Partnership® Schizophrenia Program: Reliability and stability of measures', Schizophrenia, vol. 11, no. 1, 85. https://doi.org/10.1038/s41537-025-00622-0
Harms, MP, Cho, K-IK, Anticevic, A, Bolo, NR, Bouix, S, Campbell, D, Cannon, TD, Cecchi, G, Goncalves, M, Haidar, A, Hughes, DE, Izyurov, I, John, O, Kapur, T, Kim, N, Kotler, E, Kubicki, M, Kuperman, JM, Laulette, K, Lindberg, U, Markiewicz, C, Ning, L, Poldrack, RA, Rathi, Y, Romo, PA, Tamayo, Z, Wannan, C, Wickham, A, Yassin, W, Zhou, JH, Addington, J, Alameda, L, Arango, C, Breitborde, NJK, Broome, MR, Cadenhead, KS, Calkins, ME, Chen, EYH, Choi, J, Conus, P, Corcoran, CM, Cornblatt, BA, Diaz-Caneja, CM, Ellman, LM, Fusar-Poli, P, Gaspar, PA, Gerber, C, Glenthøj, LB, Horton, LE, Hui, CLM, Kambeitz, J, Kambeitz-Ilankovic, L, Keshavan, MS, Kim, S-W, Koutsouleris, N, Kwon, JS, Langbein, K, Mamah, D, Mathalon, DH, Mittal, VA, Nordentoft, M, Pearlson, GD, Perez, J, Perkins, DO, Powers III, AR, Rogers, J, Sabb, FW, Schiffman, J, Shah, JL, Silverstein, SM, Smesny, S, Stone, WS, Strauss, GP, Thompson, JL, Upthegrove, R, Verma, SK, Wang, J, Wolf, DH, Kahn, RS, Kane, JM, McGorry, PD, Nelson, B, Woods, SW, Shenton, ME, Wood, SJ, Bearden, CE, Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ) & Pasternak, O 2025, 'The MR neuroimaging protocol for the Accelerating Medicines Partnership® Schizophrenia Program', Schizophrenia, vol. 11, no. 1, 52. https://doi.org/10.1038/s41537-025-00581-6
the Psy‐ShareD Partnership, Allen, P, Zurita, M, Easmin, R, Bucci, S, Kempton, MJ, Rogers, J, Mehta, UM, McGuire, PK, Lawrie, SM, Whalley, H, Gadelha, A, Murray, GK, Garrison, JR, Frangou, S, Upthegrove, R, Evans, SL & Kumari, V 2025, 'The Psy chosis MRI Share d D ata Resource (Psy‐ ShareD )', Human Brain Mapping, vol. 46, no. 3, e70165. https://doi.org/10.1002/hbm.70165
Chester, SC, Rogers, JC, Ogawa, T, Terao, M, Nakai, R, Abe, N & De Brito, SA 2025, 'White Matter Correlates of Psychopathic Traits in a Japanese Community Sample: Sex Matters!', European Journal of Neuroscience, vol. 62, no. 1, e70177. https://doi.org/10.1111/ejn.70177
Abstract
Addington, J, Broome, MR, Rogers, J, Upthegrove, R & Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ) 2025, 'Baseline Clinical Characterization of Participants in the Accelerating Medicines Partnership Schizophrenia Program', Schizophrenia Bulletin Open, vol. 6, no. 1, sgaf012. https://doi.org/10.1093/schizbullopen/sgaf012
Palmer, E, Upthegrove, R & Rogers, J 2025, 'Functional Connectivity Patterns Associated with Inflammation in Psychosis; Results From the UK Biobank Database', BJPsych Open, vol. 11, no. S1, pp. S12-S13. https://doi.org/10.1192/bjo.2025.10102
Review article
Palmer, ER, Taylor, MJ, Hotham, JE, Salam, D, Alshawaf, G, Rogers, JC & Upthegrove, R 2025, 'Systematic review and meta-analysis of randomized clinical trials of anti-inflammatory agents in early-stage psychotic disorders', Schizophrenia Bulletin. https://doi.org/10.1093/schbul/sbaf173
View all publications in research portal